When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Ulcerative colitis

Последний просмотренный: 12 Dec 2025
Last updated: 14 Nov 2025

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • rectal bleeding
  • diarrhea
  • blood in stool
Полная информация

Другие диагностические факторы

  • abdominal pain
  • arthritis and spondylitis
  • malnutrition
  • abdominal tenderness
  • fever
  • weight loss
  • constipation
  • skin rash
  • uveitis and episcleritis
  • pallor
Полная информация

Факторы риска

  • family history of inflammatory bowel disease
  • human leukocyte antigen-B27
  • infection
  • use of nonsteroidal anti-inflammatory drugs (NSAIDs)
  • not smoking or former smoker
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • stool studies for infective pathogens
  • fecal calprotectin (FC)
  • CBC
  • comprehensive metabolic panel (including LFTs)
  • erythrocyte sedimentation rate (ESR)
  • CRP
  • plain abdominal radiograph
  • flexible sigmoidoscopy
  • colonoscopy
  • biopsies
Полная информация

Tests to avoid

  • serologic antibody testing
Полная информация

Исследования, проведение которых нужно рассмотреть

  • CT scan
  • intestinal ultrasound
Полная информация

Алгоритм лечения

Острый

acute severe ulcerative colitis (UC)

moderate-to-severe disease

mild disease

ПРОДОЛЖЕНИЕ

disease in remission

Составители

Авторы

Andrew Poullis, BSc, MBBS, MD, FRCP

Consultant Gastroenterologist

Department of Gastroenterology

St George’s Hospital

London

UK

Раскрытие информации

AP is an author of a reference cited in this topic.

Sailish Honap, MBChB (Hons), MRes, MRCP (UK)

Consultant Gastroenterologist

Department of Gastroenterology

St George’s Hospital

London

UK

Раскрытие информации

SH has received honoraria from Pfizer (speaker, consultant, advisory board member, and received travel grants), Janssen (speaker fees, travel grants), AbbVie (speaker fees, consultant, travel grants), Takeda (speaker fees), Ferring (travel grants), Pharmacosmos (travel grants), Galapagos (travel grants).

Kamal Patel,

Раскрытие информации

all disclosures

Aaron Bhakta, BMedSci (Hons), BMBS, MSc, MRCP

Clinical Fellow in Gastroenterology

Department of Gastroenterology

St George’s Hospital

London

UK

Раскрытие информации

AB declares that he has no competing interests.

Выражение благодарностей

Dr Hesam A. Nooredinvand, and Dr Andrew Poullis would like to gratefully acknowledge Dr Ben Shandro, Dr Anet Soubieres, Dr Rhys Hewett, Dr Willem J.S. de Villiers, and Dr Houssam Mardini, previous contributors to this topic.

Раскрытие информации

BS, AS, RH, WJSD, and HM declare that they have no competing interests.

Рецензенты

Stephen B Hanauer, MD

Professor of Medicine

Gastroenterology and Hepatology

Northwestern University

Evanston

IL

Раскрытие информации

SW declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

World Gastroenterology Organisation. Global guidelines: inflammatory bowel disease. Aug 2015 [internet publication].Полный текст

Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline update: ulcerative colitis in adults. Am J Gastroenterol. 2025 Jun 3;120(6):1187-224.Полный текст  Аннотация

Moran GW, Gordon M, Sinopolou V, et al. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut. 2025 Jun 23;74(Suppl 2):s1-101.Полный текст  Аннотация

Singh S, Loftus EV Jr, Limketkai BN, et al. AGA living clinical practice guideline on pharmacological management of moderate-to-severe ulcerative colitis. Gastroenterology. 2024 Dec;167(7):1307-43.Полный текст  Аннотация

Harbord M, Eliakim R, Bettenworth D, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 2017 Jul 1;11(7):769-84.Полный текст  Аннотация

National Institute for Health and Care Excellence (UK). Ulcerative colitis: management. May 2019 [internet publication].Полный текст

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности